Cao F - Search Results

1

Temporal trends in the prevalence of autoimmune diseases from 1990 to 2019.

Cao F, Liu YC, Ni QY, Chen Y, Wan CH, Liu SY, Tao LM, Jiang ZX, Ni J, Pan HF. Cao F, et al. Autoimmun Rev. 2023 Aug;22(8):103359. doi: 10.1016/j.autrev.2023.103359. Epub 2023 May 16. Autoimmun Rev. 2023. PMID: 37201621 Review.

2

P2X7 receptor: A potential therapeutic target for autoimmune diseases.

Cao F, Hu LQ, Yao SR, Hu Y, Wang DG, Fan YG, Pan GX, Tao SS, Zhang Q, Pan HF, Wu GC. Cao F, et al. Autoimmun Rev. 2019 Aug;18(8):767-777. doi: 10.1016/j.autrev.2019.06.009. Epub 2019 Jun 7. Autoimmun Rev. 2019. PMID: 31181327 Review.

3

Therapeutic potential of aryl hydrocarbon receptor in autoimmunity.

Wang XS, Cao F, Zhang Y, Pan HF. Wang XS, et al. Among authors: cao f. Inflammopharmacology. 2020 Feb;28(1):63-81. doi: 10.1007/s10787-019-00651-z. Epub 2019 Oct 15. Inflammopharmacology. 2020. PMID: 31617124 Review.

4

Therapeutic potential of enhancer of zeste homolog 2 in autoimmune diseases.

Yang YX, Shen HH, Cao F, Xie LY, Zhu GL, Sam NB, Wang DG, Pan HF. Yang YX, et al. Among authors: cao f. Expert Opin Ther Targets. 2019 Dec;23(12):1015-1030. doi: 10.1080/14728222.2019.1696309. Epub 2019 Nov 28. Expert Opin Ther Targets. 2019. PMID: 31747802 Review.

5

Natural Products: Experimental Efficient Agents for Inflammatory Bowel Disease Therapy.

Cao F, Liu J, Sha BX, Pan HF. Cao F, et al. Curr Pharm Des. 2019;25(46):4893-4913. doi: 10.2174/1381612825666191216154224. Curr Pharm Des. 2019. PMID: 31840596 Review.

6

Pentraxin 3: A promising therapeutic target for autoimmune diseases.

Wu Q, Cao F, Tao J, Li X, Zheng SG, Pan HF. Wu Q, et al. Among authors: cao f. Autoimmun Rev. 2020 Dec;19(12):102584. doi: 10.1016/j.autrev.2020.102584. Epub 2020 Jun 10. Autoimmun Rev. 2020. PMID: 32534154 Review.

7

Natural products action on pathogenic cues in autoimmunity: Efficacy in systemic lupus erythematosus and rheumatoid arthritis as compared to classical treatments.

Cao F, Cheng MH, Hu LQ, Shen HH, Tao JH, Li XM, Pan HF, Gao J. Cao F, et al. Pharmacol Res. 2020 Oct;160:105054. doi: 10.1016/j.phrs.2020.105054. Epub 2020 Jul 6. Pharmacol Res. 2020. PMID: 32645358 Review.

8

Emerging role of air pollution in chronic kidney disease.

Chen Y, Cao F, Xiao JP, Fang XY, Wang XR, Ding LH, Wang DG, Pan HF. Chen Y, et al. Among authors: cao f. Environ Sci Pollut Res Int. 2021 Oct;28(38):52610-52624. doi: 10.1007/s11356-021-16031-6. Epub 2021 Aug 26. Environ Sci Pollut Res Int. 2021. PMID: 34448134 Review.

9

Association between meteorological factors and hospital admissions for uveitis in Hefei, China: a time-series study.

Cao F, He YS, Xiang K, Wan CH, Liu W, Gui YC, Pan HF, Jiang ZX, Tao LM. Cao F, et al. Environ Sci Pollut Res Int. 2022 Jun;29(30):45783-45792. doi: 10.1007/s11356-022-19092-3. Epub 2022 Feb 12. Environ Sci Pollut Res Int. 2022. PMID: 35149948

10

Dickkopf-1 as a promising therapeutic target for autoimmune diseases.

Tao SS, Cao F, Sam NB, Li HM, Feng YT, Ni J, Wang P, Li XM, Pan HF. Tao SS, et al. Among authors: cao f. Clin Immunol. 2022 Dec;245:109156. doi: 10.1016/j.clim.2022.109156. Epub 2022 Oct 17. Clin Immunol. 2022. PMID: 36257529 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,583 results

Search Page

Filters